LivaNova PLC Other Depreciation and Amortization
LivaNova PLC (LIVN) reported Other Depreciation and Amortization of $17.21 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherDepreciationAndAmortization · last filed 2025-02-25
- LivaNova PLC other depreciation and amortization for the quarter ending 2024-12-31 was $4.25M, a 32.97% decline year-over-year.
- LivaNova PLC other depreciation and amortization for the quarter ending 2024-09-30 was $4.34M, a 31.92% decline year-over-year.
- LivaNova PLC other depreciation and amortization for the quarter ending 2024-06-30 was $4.29M, a 32.95% decline year-over-year.
- LivaNova PLC other depreciation and amortization for the quarter ending 2024-03-31 was $4.33M, a 31.88% decline year-over-year.
- LivaNova PLC other depreciation and amortization for fiscal 2024 was $17.21M, a 32.43% decline from fiscal 2023.
- LivaNova PLC other depreciation and amortization for fiscal 2023 was $25.47M, a 1.09% increase from fiscal 2022.
- LivaNova PLC other depreciation and amortization for fiscal 2022 was $25.20M, a 4.97% decline from fiscal 2021.
- LivaNova PLC other depreciation and amortization for fiscal 2021 was $26.52M, a 30.79% decline from fiscal 2020.
| Period end | Other Depreciation and Amortization 3 month | Other Depreciation and Amortization 6 month | Other Depreciation and Amortization 9 month | Other Depreciation and Amortization 12 month |
|---|---|---|---|---|
| 2024-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $8.60M derived: sum of 2 quarters · filed 2025-02-25 | $12.88M derived: sum of 3 quarters · filed 2025-02-25 | $17.21M 10-K · filed 2025-02-25 |
| 2024-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $8.63M derived: sum of 2 quarters · filed 2024-10-31 | $12.96M 10-Q · filed 2024-10-31 | $19.30M derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $8.62M 10-Q · filed 2024-08-01 | $14.96M derived: sum of 3 quarters · filed 2025-02-25 | $21.34M derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | $4.33M 10-Q · filed 2024-05-03 | $10.67M derived: sum of 2 quarters · filed 2025-02-25 | $17.05M derived: sum of 3 quarters · filed 2025-02-25 | $23.45M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.72M derived: sum of 2 quarters · filed 2025-02-25 | $19.12M derived: sum of 3 quarters · filed 2025-02-25 | $25.47M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $12.77M derived: sum of 2 quarters · filed 2024-10-31 | $19.13M 10-Q · filed 2024-10-31 | $25.36M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $12.75M 10-Q · filed 2024-08-01 | $18.98M derived: sum of 3 quarters · filed 2025-02-25 | $25.03M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $6.36M 10-Q · filed 2024-05-03 | $12.58M derived: sum of 2 quarters · filed 2025-02-25 | $18.64M derived: sum of 3 quarters · filed 2025-02-25 | $25.09M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.28M derived: sum of 2 quarters · filed 2025-02-25 | $18.73M derived: sum of 3 quarters · filed 2025-02-25 | $25.20M 10-K · filed 2025-02-25 |
| 2022-09-30 | $6.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $12.51M derived: sum of 2 quarters · filed 2023-11-01 | $18.97M 10-Q · filed 2023-11-01 | $25.48M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $12.92M 10-Q · filed 2023-07-26 | $19.43M derived: sum of 3 quarters · filed 2024-02-29 | $26.08M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $6.46M 10-Q · filed 2023-05-03 | $12.98M derived: sum of 2 quarters · filed 2024-02-29 | $19.63M derived: sum of 3 quarters · filed 2024-02-29 | $26.28M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $13.16M derived: sum of 2 quarters · filed 2024-02-29 | $19.82M derived: sum of 3 quarters · filed 2024-02-29 | $26.52M 10-K · filed 2024-02-29 |
| 2021-09-30 | $6.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $13.31M derived: sum of 2 quarters · filed 2022-11-02 | $20.00M 10-Q · filed 2022-11-02 | $28.97M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $6.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $13.35M 10-Q · filed 2022-08-03 | $22.32M derived: sum of 3 quarters · filed 2023-02-27 | $32.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $6.70M 10-Q · filed 2022-05-04 | $15.66M derived: sum of 2 quarters · filed 2023-02-27 | $25.35M derived: sum of 3 quarters · filed 2023-02-27 | $34.74M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $18.65M derived: sum of 2 quarters · filed 2023-02-27 | $28.05M derived: sum of 3 quarters · filed 2023-02-27 | $38.31M 10-K · filed 2023-02-27 |
| 2020-09-30 | $9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $19.08M derived: sum of 2 quarters · filed 2021-11-03 | $29.35M 10-Q · filed 2021-11-03 | $40.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $9.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $19.66M 10-Q · filed 2021-07-28 | $30.35M derived: sum of 3 quarters · filed 2022-03-01 | $41.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $10.27M 10-Q · filed 2021-04-28 | $20.95M derived: sum of 2 quarters · filed 2022-03-01 | $32.10M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $10.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.83M derived: sum of 2 quarters · filed 2022-03-01 | $40.38M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $11.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $29.69M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $18.54M 10-Q · filed 2020-07-29 | |||
| 2018-12-31 | $37.19M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |